Literature DB >> 19077454

Pancreatic intraepithelial neoplasia revisited and updated.

B Sipos1, S Frank, T Gress, S Hahn, G Klöppel.   

Abstract

Most pancreatic neoplasms are classified as ductal adenocarcinoma because they show a ductal phenotype, making a ductal origin very likely. The duct lesions that may give rise to pancreatic ductal adenocarcinoma have been called pancreatic intraepithelial neoplasia (PanIN). A classification system for these lesions distinguishes between three grades of PanIN. Molecular studies revealed that PanIN-2 and PanIN-3 lesions represent a distinct step towards invasive carcinoma. While high-grade PanINs are extremely rare in the normal pancreas, low-grade PanINs are common in individuals older than 40 years and may be associated with lobular fibrosis and intraductal papillary mucinous neoplasms of the gastric type. This disease spectrum has also been described in members of kindreds with familial pancreatic cancer. The natural history and cause of PanINs are unknown. As PanIN-1 lesions entail little risk, while PanIN-3 lesions are high-risk lesions, it would be of interest to target PanIN-2 lesions, which can be regarded as the starting point of progressive neoplastic changes that lead to invasive pancreatic ductal adenocarcinoma. Global gene expression analysis identified several differentially expressed genes which show enhanced expression in PanINs and may be used as potential biomarkers to facilitate diagnosis and therapy. Copyright 2008 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077454     DOI: 10.1159/000178874

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  44 in total

1.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

2.  Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jing-Jing Zhang; Yi Zhu; Yan Zhu; Jun-Li Wu; Wen-Biao Liang; Rong Zhu; Ze-Kuan Xu; Qing Du; Yi Miao
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

3.  Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis.

Authors:  Huw B Jones; Jaimini Reens; Simon R Brocklehurst; Catherine J Betts; Sue Bickerton; Alison L Bigley; Richard P Jenkins; Nicky M Whalley; Derrick Morgan; David M Smith
Journal:  Int J Exp Pathol       Date:  2014-02       Impact factor: 1.925

Review 4.  Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Authors:  Irene Esposito; Björn Konukiewitz; Anna Melissa Schlitter; Günter Klöppel
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  [Chronic pancreatitis with pseudocysts?].

Authors:  L Veits; M Vieth; A Agaimy
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

6.  Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions.

Authors:  B-J Wang; L Wang; S-Y Yang; Z-J Liu
Journal:  Clin Transl Oncol       Date:  2014-09-03       Impact factor: 3.405

7.  Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.

Authors:  Qing Zhao; Asif Rashid; Yun Gong; Matthew H Katz; Jeffrey E Lee; Robert Wolf; Aparna Balachandran; Gauri R Varadhachary; Peter W Pisters; Hua Wang; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Ann Diagn Pathol       Date:  2011-11-03       Impact factor: 2.090

8.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

Review 9.  Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications.

Authors:  Praveen Guturu; Vijay Shah; Raul Urrutia
Journal:  J Gastrointest Cancer       Date:  2009-06-10

Review 10.  Surveillance for gastrointestinal malignancies.

Authors:  Ashish K Tiwari; Heather S Laird-Fick; Ramesh K Wali; Hemant K Roy
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.